{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:48:36Z","timestamp":1790642916512,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,30]],"date-time":"2016-09-30T00:00:00Z","timestamp":1475193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1038\/cdd.2016.105","type":"journal-article","created":{"date-parts":[[2016,9,30]],"date-time":"2016-09-30T14:55:32Z","timestamp":1475247332000},"page":"111-119","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Functional disparities among BCL-2 members in tonsillar and leukemic B-cell subsets assessed by BH3-mimetic profiling"],"prefix":"10.1038","volume":"24","author":[{"given":"Victor","family":"Peperzak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Slinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Ter Burg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Eldering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,30]]},"reference":[{"key":"BFcdd2016105_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrm3722","volume":"15","author":"PE Czabotar","year":"2014","unstructured":"Czabotar PE, Lessene G, Strasser A, Adams JM . Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol 2014; 15: 49\u201363.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFcdd2016105_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1600-065X.2012.01123.x","volume":"247","author":"V Peperzak","year":"2012","unstructured":"Peperzak V, Vikstrom IB, Tarlinton DM . Through a glass less darkly: apoptosis and the germinal center response to antigen. Immunol Rev 2012; 247: 93\u2013106.","journal-title":"Immunol Rev"},{"key":"BFcdd2016105_CR3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nm.3048","volume":"19","author":"AJ Souers","year":"2013","unstructured":"Souers AJ, Leverson JD, Boghaert ER, Ackler SL, Catron ND, Chen J et al. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med 2013; 19: 202\u2013208.","journal-title":"Nat Med"},{"key":"BFcdd2016105_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature08646","volume":"463","author":"M Schwickart","year":"2010","unstructured":"Schwickart M, Huang X, Lill JR, Liu J, Ferrando R, French DM et al. Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival. Nature 2010; 463: 103\u2013107.","journal-title":"Nature"},{"key":"BFcdd2016105_CR5","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1182\/blood.V91.9.3379","volume":"91","author":"S Kitada","year":"1998","unstructured":"Kitada S, Andersen J, Akar S, Zapata JM, Takayama S, Krajewski S et al. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses. Blood 1998; 91: 3379\u20133389.","journal-title":"Blood"},{"key":"BFcdd2016105_CR6","doi-asserted-by":"publisher","first-page":"R139","DOI":"10.1186\/gb-2008-9-9-r139","volume":"9","author":"S Kilpinen","year":"2008","unstructured":"Kilpinen S, Autio R, Ojala K, Iljin K, Bucher E, Sara H et al. Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues. Genome Biol 2008; 9: R139.","journal-title":"Genome Biol"},{"key":"BFcdd2016105_CR7","doi-asserted-by":"publisher","first-page":"e1590","DOI":"10.1038\/cddis.2014.561","volume":"6","author":"JD Leverson","year":"2015","unstructured":"Leverson JD, Zhang H, Chen J, Tahir SK, Phillips DC, Xue J et al. Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax). Cell Death Dis 2015; 6: e1590.","journal-title":"Cell Death Dis"},{"key":"BFcdd2016105_CR8","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/nchembio.1246","volume":"9","author":"G Lessene","year":"2013","unstructured":"Lessene G, Czabotar PE, Sleebs BE, Zobel K, Lowes KN, Adams JM et al. Structure-guided design of a selective BCL-X(L) inhibitor. Nat Chem Biol 2013; 9: 390\u2013397.","journal-title":"Nat Chem Biol"},{"key":"BFcdd2016105_CR9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrc1589","volume":"5","author":"R K\u00fcppers","year":"2005","unstructured":"K\u00fcppers R . Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer 2005; 5: 251\u2013262.","journal-title":"Nat Rev Cancer"},{"key":"BFcdd2016105_CR10","first-page":"5501","volume":"54","author":"S Krajewski","year":"1994","unstructured":"Krajewski S, Krajewska M, Shabaik A, Wang HG, Irie S, Fong L et al. Immunohistochemical analysis of in vivo patterns of Bcl-X expression. Cancer Res 1994; 54: 5501\u20135507.","journal-title":"Cancer Res"},{"key":"BFcdd2016105_CR11","first-page":"515","volume":"145","author":"S Krajewski","year":"1994","unstructured":"Krajewski S, Bodrug S, Gascoyne R, Berean K, Krajewska M, Reed JC . Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes. Am J Pathol 1994; 145: 515\u2013525.","journal-title":"Am J Pathol"},{"key":"BFcdd2016105_CR12","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1182\/blood.V88.4.1359.bloodjournal8841359","volume":"88","author":"JM Tuscano","year":"1996","unstructured":"Tuscano JM, Druey KM, Riva A, Pena J, Thompson CB, Kehrl JH . Bcl-x rather than Bcl-2 mediates CD40-dependent centrocyte survival in the germinal center. Blood 1996; 88: 1359\u20131364.","journal-title":"Blood"},{"key":"BFcdd2016105_CR13","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1126\/science.1191793","volume":"330","author":"I Vikstrom","year":"2010","unstructured":"Vikstrom I, Carotta S, Luthje K, Peperzak V, Jost PJ, Glaser S et al. Mcl-1 is essential for germinal center formation and B cell memory. Science 2010; 330: 1095\u20131099.","journal-title":"Science"},{"key":"BFcdd2016105_CR14","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1182\/blood-2012-03-415380","volume":"120","author":"GD Victora","year":"2012","unstructured":"Victora GD, Dominguez-Sola D, Holmes AB, Deroubaix S, Dalla-Favera R, Nussenzweig MC . Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas. Blood 2012; 120: 2240\u20132248.","journal-title":"Blood"},{"key":"BFcdd2016105_CR15","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.canlet.2011.12.021","volume":"332","author":"V Del Gaizo Moore","year":"2013","unstructured":"Del Gaizo Moore V, Letai A . BH3 profiling\u2014measuring integrated function of the mitochondrial apoptotic pathway to predict cell fate decisions. Cancer Lett 2013; 332: 202\u2013205.","journal-title":"Cancer Lett"},{"key":"BFcdd2016105_CR16","doi-asserted-by":"publisher","first-page":"10538","DOI":"10.1038\/ncomms10538","volume":"7","author":"J Lopez","year":"2016","unstructured":"Lopez J, Bessou M, Riley JS, Giampazolias E, Todt F, Rocheq\u00fce T et al. Mito-priming as a method to engineer Bcl-2 addiction. Nat Commun 2016; 7: 10538.","journal-title":"Nat Commun"},{"key":"BFcdd2016105_CR17","first-page":"e302","volume":"100","author":"R Thijssen","year":"2015","unstructured":"Thijssen R, Slinger E, Weller K, Geest CR, Beaumont T, van Oers MH et al. Resistance to ABT-199 induced by microenvironmental signals in chronic lymphocytic leukemia can be counteracted by CD20 antibodies or kinase inhibitors. Hematologica 2015; 100: e302\u2013e306.","journal-title":"Hematologica"},{"key":"BFcdd2016105_CR18","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3390\/cells3020418","volume":"3","author":"B Mojsa","year":"2014","unstructured":"Mojsa B, Lasso I, Desagher S . Mcl-1 ubiquitination: unique regulation of an essential survival protein. Cells 2014; 3: 418\u2013437.","journal-title":"Cells"},{"key":"BFcdd2016105_CR19","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1126\/science.1213368","volume":"336","author":"AM Khalil","year":"2012","unstructured":"Khalil AM, Cambier JC, Shlomchik MJ . B cell receptor signal transduction in the GC is short-circuited by high phosphatase activity. Science 2012; 336: 1178\u20131181.","journal-title":"Science"},{"key":"BFcdd2016105_CR20","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1513257","volume":"374","author":"AW Roberts","year":"2016","unstructured":"Roberts AW, Davids MS, Pagel JM, Kahl BS, Puwada SD, Gerecitano JF et al. Targeting BCL2 with venetoclax in relapsed chronic lymphocytic leukemia. N Engl J Med 2016; 374: 311\u2013322.","journal-title":"N Engl J Med"},{"key":"BFcdd2016105_CR21","doi-asserted-by":"publisher","first-page":"5141","DOI":"10.1182\/blood-2008-03-146704","volume":"112","author":"DY Hallaert","year":"2008","unstructured":"Hallaert DY, Jaspers A, van Noesel CJ, van Oers MH, Kater AP, Eldering E . c-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemoresistant niches. Blood 2008; 112: 5141\u20135149.","journal-title":"Blood"},{"key":"BFcdd2016105_CR22","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/cdd.2015.50","volume":"22","author":"ARD Delbridge","year":"2015","unstructured":"Delbridge ARD, Strasser A . The BCL-2 protein family, BH3-mimetics and cancer therapy. Cell Death Differ 2015; 22: 1071\u20131080.","journal-title":"Cell Death Differ"},{"key":"BFcdd2016105_CR23","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.cell.2005.06.009","volume":"121","author":"Q Zhong","year":"2005","unstructured":"Zhong Q, Gao W, Du F, Wang X . Mule\/ARF-BP1, a BH3 only E3 ubiquitin ligase, catalyses the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 2005; 121: 1085\u20131095.","journal-title":"Cell"},{"key":"BFcdd2016105_CR24","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1073\/pnas.1321259110","volume":"111","author":"T Okamoto","year":"2014","unstructured":"Okamoto T, Coultas L, Metcalf D, van Delft MF, Glaser SP, Takiguchi M et al. Enhanced stability of Mcl1, a prosurvival Bcl2 relative, blunts stress-induced apoptosis, causes male sterility, and promotes tumorigenesis. Proc Natl Acad Sci U S A 2014; 111: 261\u2013266.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFcdd2016105_CR25","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1101\/gad.1093903","volume":"17","author":"D Nijhawan","year":"2003","unstructured":"Nijhawan D, Fang M, Traer E, Zhong Q, Gao W, Du F et al. Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev 2003; 17: 1475\u20131486.","journal-title":"Genes Dev"},{"key":"BFcdd2016105_CR26","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1007\/s10495-011-0599-8","volume":"16","author":"FM Wensveen","year":"2011","unstructured":"Wensveen FM, Alves NL, Derks IA, Reedquist KA, Eldering E . Apoptosis induced by overall metabolic stress converges on the Bcl-2 family proteins Noxa and Mcl-1. Apoptosis 2011; 16: 708\u2013721.","journal-title":"Apoptosis"},{"key":"BFcdd2016105_CR27","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature09732","volume":"471","author":"H Inuzuka","year":"2011","unstructured":"Inuzuka H, Shaik S, Onoyama I, Gao D, Tseng A, Maser RS et al. SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitination and destruction. Nature 2011; 471: 104\u2013109.","journal-title":"Nature"},{"key":"BFcdd2016105_CR28","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature09779","volume":"471","author":"IE Wertz","year":"2011","unstructured":"Wertz IE, Kusam S, Lam C, Okamoto T, Sandoval W, Anderson DJ et al. Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7. Nature 2011; 471: 110\u2013114.","journal-title":"Nature"},{"key":"BFcdd2016105_CR29","doi-asserted-by":"publisher","first-page":"6025","DOI":"10.4049\/jimmunol.166.10.6025","volume":"166","author":"A Jiang","year":"2001","unstructured":"Jiang A, Clark EA . Involvement of Bik, a proapoptotic member of the Bcl-2 family, in surface IgM-mediated B cell apoptosis. J Immunol 2001; 166: 6025\u20136033.","journal-title":"J Immunol"},{"key":"BFcdd2016105_CR30","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/cdd.2008.183","volume":"16","author":"LC Spender","year":"2009","unstructured":"Spender LC, O\u2019Brien DI, Simpson D, Dutt D, Gregory CD, Allday MJ et al. TGF-beta induces apoptosis in human B cells by transcriptional regulation of BIK and BCL-XL. Cell Death Differ 2009; 16: 593\u2013602.","journal-title":"Cell Death Differ"},{"key":"BFcdd2016105_CR31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/cdd.2015.97","volume":"23","author":"MJ Carter","year":"2016","unstructured":"Carter MJ, Cox KL, Blakemore SJ, Bogdanov YD, Happo L, Scott CL et al. BCR-signaling-induced cell death demonstrates dependency on multiple BH3-only proteins in a murine model of B-cell lymphoma. Cell Death Differ 2016; 23: 303\u2013312.","journal-title":"Cell Death Differ"},{"key":"BFcdd2016105_CR32","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/sj.leu.2403623","volume":"19","author":"WJM Mackus","year":"2005","unstructured":"Mackus WJM, Kater AP, Grummels A, Evers LM, Hooijbrink B, Kramer MH et al. Chronic lymphocytic leukemia cells display p53-dependent drug-induced Puma upregulation. Leukemia 2005; 19: 427\u2013434.","journal-title":"Leukemia"},{"key":"BFcdd2016105_CR33","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1038\/sj.cdd.4402211","volume":"14","author":"DY Hallaert","year":"2007","unstructured":"Hallaert DY, Spijker R, Jak M, Derks IA, Alves NL, Wensveen FM et al. Crosstalk among Bcl-2 famliy members in B-CLL: seliciclib acts via the Mcl-1\/Noxa axis and gradual exhaustion of Bcl-2 protection. Cell Death Differ 2007; 14: 1958\u20131967.","journal-title":"Cell Death Differ"},{"key":"BFcdd2016105_CR34","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1182\/blood-2007-09-110858","volume":"111","author":"E Belnoue","year":"2008","unstructured":"Belnoue E, Pihlgren M, McGaha TL, Tougne C, Rochat AF, Bossen C et al. APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells. Blood 2008; 111: 2755\u20132764.","journal-title":"Blood"},{"key":"BFcdd2016105_CR35","doi-asserted-by":"publisher","first-page":"10967","DOI":"10.1073\/pnas.1005256107","volume":"107","author":"EM Carrington","year":"2010","unstructured":"Carrington EM, Vikstrom IB, Light A, Sutherland RM, Londrigan SL, Mason KD et al. BH3 mimetics antagonizing restricted prosurvival Bcl-2 proteins represent another class of selective immune modulatory drugs. Proc Natl Acad Sci U S A 2010; 107: 10967\u201310971.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFcdd2016105_CR36","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/ni.2527","volume":"14","author":"V Peperzak","year":"2013","unstructured":"Peperzak V, Vikstrom I, Walker J, Glaser SP, LePage M, Coquery CM et al. Mcl-1 is essential for the survival of plasma cells. Nat Immunol 2013; 14: 290\u2013297.","journal-title":"Nat Immunol"},{"key":"BFcdd2016105_CR37","doi-asserted-by":"publisher","first-page":"23629","DOI":"10.1074\/jbc.M114.569376","volume":"289","author":"BT Gaudette","year":"2014","unstructured":"Gaudette BT, Iwakoshi NN, Boise LH . Bcl-xL protein protects from C\/EBP homologous protein (CHOP)-dependent apoptosis during plasma cell differentiation. J Biol Chem 2014; 289: 23629\u201323640.","journal-title":"J Biol Chem"},{"key":"BFcdd2016105_CR38","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.cell.2007.01.037","volume":"128","author":"KD Mason","year":"2007","unstructured":"Mason KD, Carpinelli MR, Fletcher JI, Collinge JE, Hilton AA, Ellis S et al. Programmed anuclear cell death delimits platelet life span. Cell 2007; 128: 1173\u20131186.","journal-title":"Cell"},{"key":"BFcdd2016105_CR39","doi-asserted-by":"publisher","first-page":"917","DOI":"10.2353\/ajpath.2007.070005","volume":"171","author":"JM van Laar","year":"2007","unstructured":"van Laar JM, Melchers M, Teng YK, van der Zouwen B, Mohammadi R, Fischer R et al. Sustained secretion of immunoglobulin by long-lived human tonsil plasma cells. Am J Pathol 2007; 171: 917\u2013927.","journal-title":"Am J Pathol"},{"key":"BFcdd2016105_CR40","doi-asserted-by":"publisher","first-page":"6032","DOI":"10.1182\/blood-2011-12-399089","volume":"119","author":"E Ottina","year":"2012","unstructured":"Ottina E, Grespi F, Tischner D, Soratroi C, Geley S, Ploner A et al. Targeting antiapoptotic A1\/Bfl-1 by in vivo RNAi reveals multiple roles in leukocyte development in mice. Blood 2012; 119: 6032\u20136042.","journal-title":"Blood"},{"key":"BFcdd2016105_CR41","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/cdd.2015.130","volume":"23","author":"M Sochalska","year":"2016","unstructured":"Sochalska M, Ottina E, Tuzlak S, Herzog S, Herold M, Villunger A . Conditional knockdown of BCL2A1 reveals rate-limiting roles in BCR-dependent B-cell survival. Cell Death Differ 2016; 23: 628\u2013639.","journal-title":"Cell Death Differ"},{"key":"BFcdd2016105_CR42","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1093\/nar\/gng153","volume":"31","author":"E Eldering","year":"2003","unstructured":"Eldering E, Spek CA, Aberson HL, Grummels A, Derks IA, de Vos AF et al. Expression profiling via novel multiplex assay allows rapid assessment of gene regulation in defined signalling pathways. Nucleic Acids Res 2003; 31: e153.","journal-title":"Nucleic Acids Res"}],"container-title":["Cell Death & Differentiation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cdd2016105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cdd2016105","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cdd2016105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:09:59Z","timestamp":1684415399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cdd2016105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,30]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["BFcdd2016105"],"URL":"https:\/\/doi.org\/10.1038\/cdd.2016.105","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,30]]},"assertion":[{"value":"11 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}